The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

Lisa Haile

Tel:
Work +1 858 677 1456
Email:
DLA Piper LLP (US)

Work Department

Energy

Position

Partner and Co-Chair of DLA Piper's S Global Life Sciences Sector

Career

Dr. Lisa Haile concentrates on patent protection.

Dr. Haile has special technical experience in molecular biology, immunology, cell biology, regenerative medicine including ESCs, iPSCs, pSCs, diagnostics, therapeutics, theranostics, drug delivery systems, host-vector systems, high throughput screening and bioinformatics. She has particular experience with patentability, non-infringement and validity opinions; licensing strategies; FDA counseling; due diligence work in connection with venture capital, private and public financing; mergers and acquisitions in the life sciences industry; and strategic counseling for comprehensive life sciences patent portfolio management

Education

JD, California Western School of Law; Ph.D, Georgetown University School of Medicine; BA Rollins College


United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

DLA Piper LLP (US)’s ‘excellent, responsive and knowledgeable’ department has considerable experience assisting high-profile clients with regulatory, transactional and IP matters, as well as complex global disputes. San Diego-based co-head Lisa Haile and New York-based Stuart Pollack have been leading advice to SteadyMed on various patent invalidation claims brought against United Therapeutics before the Patent Trial and Appeal Board (PTAB). Co-head Richard Mulloy and Drew Wintringham, who are in San Diego and New York, respectively, have been representing Covidien in patent litigation brought against Ethicon arising from the release of Ethicon’s Enseal X1 medical device. The team also acted for Sanpower Group on its $820m acquisition of Dendreon Pharmaceuticals. Also led by product liability expert Matthew Holian in Boston, the team includes George Karavetsos in Miami, Loren Brown in New York, Raymond Williams in Philadelphia, Larry Nishnick in San Diego and Aaron Fountain, who splits his time between Austin and Houston.

[back to top]

United States: Intellectual property

Patents: licensing

Within: Patents: licensing

With a particular strong standing in the life sciences and technology industries, DLA Piper LLP (US) demonstrates expertise in transactional licensing, including mergers and acquisitions, spin-offs, and asset sales, flanked by a strong due diligence track record; settlement negotiations, in particular with non-practicing entities, as well as domestic and international research and development agreements are other focus areas. The San Diego-based Mark Lehberg led advice to Qualcomm on a large number of cross-border licence agreements in the context of its $3bn joint venture with TDK. The team also assisted Geneius Biotechnology with the creation of its patent portfolio in the personalized oncology therapeutic platform space. In other work, San Diego’s Lisa Haile was key in obtaining a notice of allowance for Revolution Contraceptive from the Parsemus Foundation regarding a reversible male contraceptive. The Philadelphia-based Darius Gambino and Mike McGurk in Boston are other noteworthy practitioners. Clients also include Nanotherapeutics and the University of Texas at Austin.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to